PHARMACIE DAVOINE
0444.488.642 · rovalta.com · 25/09/2026
PHARMACIE DAVOINE
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPHARMACIE DAVOINE is a Public limited company incorporated in 1991. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Forest. It employs on average 3,5 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0444.488.642
- Incorporation
- 26/06/1991
- Legal form
- Public limited company
- Registered office
- Rue des Châtaignes 21
1190 Forest · BruxellesSee on map - Contributed capital
- 62 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 3,5 ETP
Joint committees (2)
- 313
- 3130
Financials
Source · NBB, 20 filingsTrend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 359,9 k € | -19.9% | 449,3 k € | -31.1% | 652 k € | +4.3% | 624,9 k € | +8.7% | 574,7 k € |
| EBITDA | 76 k € | -59.3% | 186,7 k € | -69.9% | 620,1 k € | +0.3% | 618,5 k € | +9.0% | 567,4 k € |
| Operating result | 3,3 k € | -97.6% | 139,6 k € | -75.1% | 560,9 k € | -0.5% | 564 k € | +9.9% | 513,1 k € |
| Net result | -46,7 k € | -149% | 95,9 k € | -81.7% | 524 k € | -2.5% | 537,6 k € | +11.9% | 480,7 k € |
| Balance sheet | |||||||||
| Equity | 144,5 k € | -24.4% | 191,2 k € | +0.0% | 191,1 k € | +0.0% | 191,1 k € | +5.2% | 181,7 k € |
| Total assets | 2 M € | +20.0% | 1,6 M € | +0.9% | 1,6 M € | +5.6% | 1,5 M € | +1.7% | 1,5 M € |
| Cash | 26,1 k € | -65.8% | 76,1 k € | -29.2% | 107,6 k € | +101% | 53,4 k € | -28.4% | 74,7 k € |
| Debts | 1,8 M € | +25.9% | 1,5 M € | +1.0% | 1,4 M € | +7.8% | 1,3 M € | +12.8% | 1,2 M € |
| Other | |||||||||
| Workforce | 3,5 ETP | -7.9% | 3,8 ETP | +1167% | 0,3 ETP | – | – | ||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20253 active · 13 ended
Active mandates
Other companies at this address
Rue des Châtaignes 21 1190 Forest| Company | CBE no. |
|---|---|
ALEXARA● Active | 1023.674.256 |
CLAREXIS & CO● Active | 1002.062.656 |
DAVOINE● Active | 0471.519.572 |
PHARMACIE DUFRANE● Active | 0477.954.434 |
SPYPHARMA● Active | 0419.976.247 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/08/2026 | 29/08/2025 | 27/09/2024 | 29/08/2023 | 31/10/2022 | 31/08/2021 |
| General meeting | 30/05/2026 | 31/05/2025 | 25/05/2024 | 27/05/2023 | 28/05/2022 | 29/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 30/05/2026 | 30/08/2026 | French | |
| Abridged model | 31/12/2024 | 31/05/2025 | 29/08/2025 | French | |
| Abridged model | 31/12/2023 | 25/05/2024 | 27/09/2024 | French | |
| Abridged model | 31/12/2022 | 27/05/2023 | 29/08/2023 | French | |
| Abridged model | 31/12/2021 | 28/05/2022 | 31/10/2022 | French | |
| Abridged model | 31/12/2020 | 29/05/2021 | 31/08/2021 | French | |
| Abridged model | 31/12/2019 | 31/08/2020 | 29/10/2020 | French | |
| Abridged model | 31/12/2018 | 25/05/2019 | 29/08/2019 | French | |
| Abridged model | 31/12/2017 | 26/05/2018 | 31/08/2018 | French | |
| Abridged model | 31/12/2016 | 27/05/2017 | 24/08/2017 | French | |
| Abridged model | 31/12/2015 | 28/05/2016 | 04/08/2016 | French | |
| Abridged model | 31/12/2014 | 30/05/2015 | 20/08/2015 | French | |
| Abridged model | 31/12/2013 | 31/05/2014 | 20/08/2014 | French | |
| Abridged model | 31/12/2012 | 25/05/2013 | 01/07/2013 | French | |
| Abridged model | 31/12/2011 | 16/06/2012 | 03/07/2012 | French | |
| Abridged model | 31/12/2010 | 30/06/2011 | 26/07/2011 | French | |
| Abridged model | 31/12/2009 | 29/05/2010 | 17/06/2010 | French | |
| Abridged model | 31/12/2008 | 30/05/2009 | 17/06/2009 | French | |
| Abridged model | 31/12/2007 | 31/05/2008 | 18/06/2008 | French | |
| Abridged model | 31/12/2006 | 26/05/2007 | 18/06/2007 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20253 active · 13 ended
Active mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates03/01/2025DEMISSIONS, NOMINATIONS
- Mandates13/12/2023DEMISSIONS, NOMINATIONS
- Capital / shares08/09/2022STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
- Mandates01/06/2021DEMISSIONS, NOMINATIONS
- Mandates23/02/2021DEMISSIONS, NOMINATIONS
- Mandates28/02/2014DEMISSIONS, NOMINATIONS
- Mandates17/12/2010DEMISSIONS, NOMINATIONS
- Mandates16/04/2003DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-46,7 k €↓
- 2024Annual accounts 202495,9 k €↓
- 2023Annual accounts 2023524 k €↓
- 2022Annual accounts 2022537,6 k €↑
- 2022Name changePHARMACIE DAVOINE
- 2021Annual accounts 2021480,7 k €↑
- 2021Name changePharmanadine
- 2020Annual accounts 2020440,2 k €↓
- 2019Annual accounts 2019457,2 k €↑
- 2018Annual accounts 2018330,9 k €↓
- 2017Annual accounts 2017497,4 k €↓
- 2016Annual accounts 2016502,4 k €↑
- 2015Annual accounts 2015468,8 k €↑
- 2014Annual accounts 2014345,6 k €↓
- 2013Annual accounts 2013392,6 k €↑
- 2012Annual accounts 2012360,1 k €↑
- 2011Annual accounts 2011324,9 k €↑
- 2010Annual accounts 2010266,5 k €↓
- 2009Annual accounts 2009357,9 k €↑
- 2008Annual accounts 2008268,3 k €↑
- 2007Annual accounts 2007233,7 k €↑
- 2006Annual accounts 2006185,9 k €
- 26/06/1991IncorporationPublic limited company